NEWS
![](https://oslocancercluster.no/wp-content/uploads/2023/11/tone_hovda-260x185.jpg)
Results from breast cancer screening pilot
A clinical pilot for personalised risk-based breast cancer screening has been conducted as part of the AnteNOR project. Here are some of the results.
![](https://oslocancercluster.no/wp-content/uploads/2024/04/Fremtidens-kreftbehandling-2024-9774-kopi-260x185.jpg)
Har partiene en kreftpolitikk?
During the breakfast seminar The Future of Cancer Politics four politicians discussed possible health- and cancer policies in their coming party programmes. The seminar was held in Norwegian.
![](https://oslocancercluster.no/wp-content/uploads/2024/03/DoMore-Diagnostics-Team-1920px-2-260x185.jpg)
DoMore Diagnostics secures EUR 10 million grant
In a great achievement, DoMore Diagnostics has been awarded the prestigious EIC Accelerator grant totalling EUR 10 million.
![Two scientists in a lab, smiling, on in action and one sitting](https://oslocancercluster.no/wp-content/uploads/2024/03/OCC_LAB001web-260x185.jpg)
One of Europe’s Leading Start-up Hubs
Oslo Cancer Cluster Incubator made the Financial Times Europe’s Leading Start-up Hubs list.
![Two headshots of men in a collage, black and white image.](https://oslocancercluster.no/wp-content/uploads/2024/03/Ostuni-Tuv_collage_2024_web-260x185.jpg)
What does it take to make it?
What does it take to make it for new biotech companies?
![](https://oslocancercluster.no/wp-content/uploads/2024/02/kliniske-studier-i-norge-260x185.jpg)
Advancing Cancer Research in Norway: Eli Lilly's SUNRAY-01 Study
Eli Lilly selected Norway as the site for its groundbreaking study project, despite the decline of the recent year's number of clinical cancer trials.
![](https://oslocancercluster.no/wp-content/uploads/2024/02/MoU-2-260x185.jpg)
Unique collaboration to build Nordic health industry
A new collaboration agreement between AstraZeneca, Oslo Cancer Cluster, and Oslo Science City aims to strengthen the Nordic health industry.
![](https://oslocancercluster.no/wp-content/uploads/2024/01/Cancer-Crosslinks-2024-web-27-260x185.jpg)
A peak into Cancer Crosslinks
World-leading translational cancer research entered Oslo Cancer Cluster Innovation Park last week and created a buzz.
![](https://oslocancercluster.no/wp-content/uploads/2024/01/CancerCrosslinks2023_083-260x185.jpg)
Making Cancer Crosslinks possible
Meet the sponsors behind Cancer Crosslinks 2024: Bristol Myers Squibb and Daiichi-Sankyo.